Similarly, the Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT) trial demonstrated a significant reduction in cardiovascular events in individuals with overweight or obesity, with subsequent analysis addressing prespecified kidney endpoints
T., Kadowaki T., Lingvay I., Nauck M., et al
Surgical treatment of gynecomastia leads to holistic well-being, enhancing both physical appearance and mental health
GLP-1 is short for glucagon-like peptide-1 receptor agonists, and it's a type of medication that's usually prescribed for diabetes, but is also used for weight management
Additionally, the rapid adoption of innovative oral GLP-1 therapies and favorable regulatory support drive market growth across the U.S
Table of Contents Understanding GLP-1 Therapy in Type 1 Diabetes Potential Benefits and Clinical Outcomes Risks, Safety Concerns, and Limitations Patient Selection and Practical Considerations Understanding GLP-1 Therapy in Type 1 Diabetes GLP-1 receptor agonists are well established in type 2 diabetes, yet their role in type 1 diabetes remains off-label